Clinical Trial Update: Prophylactic Effect of Nirmatrelvir/Ritonavir and Ursodeoxycholic Acid on Reducing Complications After Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing whether prophylactic nirmatrelvir/ritonavir combined with ursodeoxycholic acid can reduce complications after cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery-related Complications

Drugs mentioned

• Nirmatrelvir/ritonavir (nirmatrelvir/ritonavir)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Cardiac Surgery | Phase 4 | Status: UNKNOWN